Back

Assessment of risk in diabetic patients.

29 August 2022 (08:30 - 08:48)
Organised by:
Congress Presentation Part of: Meet the Experts: how to lower cardiovascular disease risk in patients with diabetes Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Francesco Cosentino

Karolinska University Hospital, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
All diabetic patients should be treated with GLP1 and/or GIP agonists.
Professor A. Cahn (Jerusalem, IL)
Slides Video
Presentation thumbnail
All diabetic patients should be treated with SGLT2 inhibitors.
Associate Professor L. Mellbin (Stockholm, SE)
Slides Video
Presentation thumbnail
All diabetic patients should be treated with metformin.
Professor H. Drexel (Feldkirch, AT)
Slides Video
Presentation thumbnail
Putting it all together: how to lower cardiovascular disease risk in patients with diabetes.
Professor N. Marx (Aachen, DE)
Slides Video

Access the full session

Session thumbnail
Meet the Experts: how to lower cardiovascular disease risk in patients with diabetes
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular risk stratification in clinical practice: screening tools and biomarkers
23 April 2026
thumbnail
Congress Presentation
Residual diabetic risk: from glucose lowering to cardiovascular protection.
29 August 2022
thumbnail
Congress Presentation
Assessing CV risk in patients with type 2 diabetes: lessons learned from imaging
14 April 2023
thumbnail
Congress Session
Imaging or biomarkers: which is superior in risk prediction?
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources